SS-31 Reference Guide: Mitochondria-Targeted Peptide for Cellular Research

SS-31 (also published as elamipretide and MTP-131) is a synthetic tetrapeptide developed in the Szeto-Schiller series and designed to concentrate selectively in the inner mitochondrial membrane. Unlike most peptides studied in cellular research, SS-31 does not act through a cell-surface receptor. It binds cardiolipin — a unique phospholipid found almost exclusively in the inner mitochondrial membrane — and stabilizes membrane and electron transport chain (ETC) architecture during oxidative stress.

That mechanism makes SS-31 a frequently used tool in mitochondrial bioenergetics research, where the question is not which receptor signals what, but how the inner membrane behaves under stress.

At a glance

Structure and cell entry

SS-31 is a four-residue peptide with alternating aromatic and cationic side chains. The cationic charge (+3 at physiologic pH) attracts it to the negatively charged inner mitochondrial membrane, while the aromatic residues partition into the membrane bilayer. The net effect is selective accumulation at the inner mitochondrial membrane — measured at concentrations roughly 1,000-fold higher inside mitochondria than in cytosol in cellular studies.

Critically, this accumulation does not require a cell-surface receptor or a transporter. SS-31 crosses the plasma membrane and the outer mitochondrial membrane through energy-independent uptake driven by its cationic-aromatic motif and the mitochondrial membrane potential.

The cardiolipin target

Cardiolipin is a four-chain phospholipid found almost exclusively in the inner mitochondrial membrane. It is essential for the structural organization of ETC supercomplexes and stabilizes cytochrome c at the membrane. Under oxidative stress, cardiolipin is oxidatively damaged, which disrupts ETC organization, increases ROS leak, and triggers cytochrome c release.

SS-31 binds cardiolipin and stabilizes it against peroxidation. In published research models, this preserves ETC supercomplex organization, restores oxygen consumption rate (OCR) under stress, and reduces mitochondrial ROS production. The mechanism is structural — protecting the cardiolipin scaffold — rather than antioxidant scavenging.

What research models use it

• Mitochondrial bioenergetics: OCR measurements (Seahorse, Oroboros), ATP production assays, mitochondrial membrane potential, and ETC complex activity under stress conditions.
• Oxidative stress models: ROS measurement, cardiolipin peroxidation, lipid peroxidation downstream of mitochondrial dysfunction.
• Ischemia-reperfusion (I/R) research: Cardiac and renal I/R models where mitochondrial damage is the dominant injury pathway.
• Aging-related mitochondrial decline: Skeletal muscle and cardiac models of age-related ETC dysfunction.
• Primary mitochondrial disease research: Models of Barth syndrome (cardiolipin remodeling deficiency) and other inner-membrane-phospholipid disorders.

How SS-31 differs from other “mitochondrial” compounds

The term “mitochondrial peptide” is used loosely. Two distinct categories appear in the literature:

• Mitochondrial-encoded peptides (e.g., MOTS-c, humanin) are translated from mitochondrial DNA and act as signaling molecules — they bind cell-surface or intracellular receptors and modulate transcription.
• Mitochondria-targeted peptides (e.g., SS-31) are synthetic structures designed to localize to mitochondria and stabilize membrane or ETC structure directly. No receptor is involved.

The two categories answer different research questions. MOTS-c is studied as a mitokine — a signal sent from mitochondria to the rest of the cell. SS-31 is studied as a structural stabilizer of the inner membrane itself.

For the mitokine side of mitochondrial peptide research, see the MOTS-c Reference Guide.

Lab handling

Lyophilized SS-31 is stable at −20°C for typical research timeframes. SS-31 is highly water-soluble — sterile water or bacteriostatic water reconstitutes cleanly without the cosolvents (acetic acid, DMSO) sometimes needed for hydrophobic peptides. Standard practice applies: gentle swirling rather than shaking, aliquoting before freezing, and limiting freeze-thaw cycles to preserve activity.

For a step-by-step reconstitution protocol that applies here, see How to Reconstitute BPC-157. The procedure is shared across water-soluble research peptides; only the dilution math differs by vial size.

When to choose SS-31 in a research design

• Inner mitochondrial membrane biology: cardiolipin oxidation, ETC supercomplex organization, membrane potential under stress.
• Pharmacologic mitochondrial protection arm: ischemia-reperfusion, aging, and primary mitochondrial dysfunction models.
• Receptor-independent comparison: paired with receptor-mediated mitochondrial tools (e.g., MOTS-c) to separate structural from signaling effects.

For Research Use Only. Information presented for laboratory and research applications. Not medical advice and not a substitute for qualified scientific judgment.